• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病与胰岛素抵抗的关联。

Association of nonalcoholic fatty liver disease with insulin resistance.

作者信息

Marchesini G, Brizi M, Morselli-Labate A M, Bianchi G, Bugianesi E, McCullough A J, Forlani G, Melchionda N

机构信息

Department of Internal Medicine and Gastroenterology, Cattedra di Malattie del Metabolismo, Università di Bologna, Italy.

出版信息

Am J Med. 1999 Nov;107(5):450-5. doi: 10.1016/s0002-9343(99)00271-5.

DOI:10.1016/s0002-9343(99)00271-5
PMID:10569299
Abstract

BACKGROUND AND PURPOSE

Nonalcoholic fatty liver disease is frequently associated with type 2 diabetes mellitus, obesity, and dyslipidemia, but some patients have normal glucose tolerance or normal weight. We tested the hypothesis that there is an association between nonalcoholic fatty liver disease and insulin resistance that is independent of diabetes and obesity.

SUBJECTS AND METHODS

We measured anthropometric and metabolic variables in 46 patients with chronically elevated serum aminotransferase levels, "bright liver" on ultrasound scan, and normal glucose tolerance. Indexes of insulin resistance and secretion were determined using the homeostasis model assessment method. They were compared with 92 normal subjects who were matched for age and sex.

RESULTS

Patients with nonalcoholic fatty liver disease were characterized by fasting and glucose-induced hyperinsulinemia, insulin resistance, postload hypoglycemia, and hypertriglyceridemia. Insulin resistance [odds ratio (OR) = 15 per percent increase, 95% confidence interval (CI): 3.0 to 70], fasting triglyceride level (OR = 3.1 per mmol/liter increase, 95% CI: 1.1 to 8.9), 180-minute blood glucose level (OR = 4.3 per mmol/ liter decrease, 95% CI: 1.6 to 12), and average insulin concentration in response to oral glucose (OR = 3.0 per 100 pmol/liter increase, 95% CI: 1.5 to 6.2) were independently associated with nonalcoholic fatty liver disease. The exclusion of overweight and obese subjects did not change the results.

CONCLUSION

Nonalcoholic fatty liver disease is associated with insulin resistance and hyperinsulinemia even in lean subjects with normal glucose tolerance. Genetic factors that reduce insulin sensitivity and increase serum triglyceride levels may be responsible for its development.

摘要

背景与目的

非酒精性脂肪性肝病常与2型糖尿病、肥胖和血脂异常相关,但部分患者葡萄糖耐量正常或体重正常。我们检验了以下假设:非酒精性脂肪性肝病与胰岛素抵抗之间存在独立于糖尿病和肥胖的关联。

对象与方法

我们测量了46例血清转氨酶水平长期升高、超声检查显示“明亮肝”且葡萄糖耐量正常的患者的人体测量和代谢变量。使用稳态模型评估法测定胰岛素抵抗和分泌指标。将其与92名年龄和性别匹配的正常受试者进行比较。

结果

非酒精性脂肪性肝病患者的特征为空腹及葡萄糖诱导的高胰岛素血症、胰岛素抵抗、负荷后低血糖和高甘油三酯血症。胰岛素抵抗[比值比(OR)=每增加1%为15,95%置信区间(CI):3.0至70]、空腹甘油三酯水平(OR =每增加1 mmol/升为3.1,95% CI:1.1至8.9)、180分钟血糖水平(OR =每降低1 mmol/升为4.3,95% CI:1.6至12)以及口服葡萄糖后平均胰岛素浓度(OR =每增加100 pmol/升为3.0,95% CI:1.5至6.2)均与非酒精性脂肪性肝病独立相关。排除超重和肥胖受试者后结果未改变。

结论

即使在葡萄糖耐量正常的瘦人中,非酒精性脂肪性肝病也与胰岛素抵抗和高胰岛素血症相关。降低胰岛素敏感性并增加血清甘油三酯水平的遗传因素可能导致其发生。

相似文献

1
Association of nonalcoholic fatty liver disease with insulin resistance.非酒精性脂肪性肝病与胰岛素抵抗的关联。
Am J Med. 1999 Nov;107(5):450-5. doi: 10.1016/s0002-9343(99)00271-5.
2
Association of nonalcoholic fatty liver disease with insulin resistance: is OGTT indicated in nonalcoholic fatty liver disease?非酒精性脂肪性肝病与胰岛素抵抗的关联:非酒精性脂肪性肝病患者是否需要进行口服葡萄糖耐量试验?
J Clin Gastroenterol. 2003 Nov-Dec;37(5):399-402. doi: 10.1097/00004836-200311000-00010.
3
Increased fetuin-A concentrations in impaired glucose tolerance with or without nonalcoholic fatty liver disease, but not impaired fasting glucose.在伴有或不伴有非酒精性脂肪性肝病的糖耐量受损患者中,胎球蛋白-A 浓度升高,但空腹血糖受损患者则不然。
J Clin Endocrinol Metab. 2012 Dec;97(12):4717-23. doi: 10.1210/jc.2012-2414. Epub 2012 Oct 12.
4
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.非酒精性脂肪性肝病患者转氨酶水平正常时发生严重肝病的风险:胰岛素抵抗和糖尿病的作用
Hepatology. 2008 Sep;48(3):792-8. doi: 10.1002/hep.22429.
5
Relationship between insulin resistance and serum alanine aminotransferase as a surrogate of NAFLD (nonalcoholic fatty liver disease) in obese Korean children.肥胖韩国儿童中胰岛素抵抗与作为非酒精性脂肪性肝病(NAFLD)替代指标的血清丙氨酸氨基转移酶之间的关系。
Diabetes Res Clin Pract. 2008 Sep;81(3):321-6. doi: 10.1016/j.diabres.2008.05.006. Epub 2008 Jun 20.
6
Increased insulinogenic index is an independent determinant of nonalcoholic fatty liver disease activity score in patients with normal glucose tolerance.胰岛素生成指数升高是糖耐量正常患者非酒精性脂肪性肝病活动评分的独立决定因素。
Dig Liver Dis. 2012 Nov;44(11):935-9. doi: 10.1016/j.dld.2012.06.011. Epub 2012 Jul 17.
7
Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.非酒精性脂肪性肝病超重/肥胖儿童的胰腺脂肪与β细胞功能
World J Gastroenterol. 2015 Apr 21;21(15):4688-95. doi: 10.3748/wjg.v21.i15.4688.
8
Role of hyperinsulinemia and glucose intolerance in the pathogenesis of nonalcoholic fatty liver in patients with normal body weight.高胰岛素血症和葡萄糖不耐受在体重正常的非酒精性脂肪肝患者发病机制中的作用。
Korean J Intern Med. 1998 Feb;13(1):12-4.
9
High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.2型糖尿病且血浆转氨酶水平正常患者中非酒精性脂肪性肝病的高患病率
J Clin Endocrinol Metab. 2015 Jun;100(6):2231-8. doi: 10.1210/jc.2015-1966. Epub 2015 Apr 17.
10
Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistance.非酒精性脂肪性肝病中胃饥饿素浓度低与胰岛素抵抗有关。
J Clin Endocrinol Metab. 2003 Dec;88(12):5674-9. doi: 10.1210/jc.2003-031094.

引用本文的文献

1
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes.代谢功能障碍相关脂肪性肝病(MASLD):肠道微生物群、胰岛素抵抗和糖尿病之间的相互作用
Front Med (Lausanne). 2025 Aug 14;12:1618275. doi: 10.3389/fmed.2025.1618275. eCollection 2025.
2
Multifaceted Human Antigen R (HuR): A Key Player in Liver Metabolism and MASLD.多面手人类抗原R(HuR):肝脏代谢和代谢相关脂肪性肝病中的关键角色
Livers. 2025 Sep;5(3). doi: 10.3390/livers5030033. Epub 2025 Jul 21.
3
Genomics-informed drug-repurposing strategy identifies two therapeutic targets for preventing liver disease associated with metabolic dysfunction.
基于基因组学的药物重新利用策略确定了两个预防与代谢功能障碍相关肝病的治疗靶点。
Am J Hum Genet. 2025 Aug 7;112(8):1778-1791. doi: 10.1016/j.ajhg.2025.06.014.
4
Metabolic Dysfunction-Associated Steatotic Liver Disease: From a Very Low-Density Lipoprotein Perspective.代谢功能障碍相关脂肪性肝病:从极低密度脂蛋白角度看
Biomolecules. 2025 Jul 11;15(7):990. doi: 10.3390/biom15070990.
5
Steatotic Liver Disease in Older Adults: Clinical Implications and Unmet Needs.老年人脂肪性肝病:临床意义与未满足的需求
Nutrients. 2025 Jun 30;17(13):2189. doi: 10.3390/nu17132189.
6
Relationship between glucagon and metabolic dysfunction-associated steatotic liver disease in patients with type 2 diabetes mellitus.2型糖尿病患者中胰高血糖素与代谢功能障碍相关脂肪性肝病的关系。
World J Hepatol. 2025 Jun 27;17(6):104693. doi: 10.4254/wjh.v17.i6.104693.
7
Impact of cardiometabolic risk factors on hepatic fibrosis and clinical outcomes in MASLD: A population-based multi-cohort study.代谢性心血管危险因素对非酒精性脂肪性肝病相关肝纤维化及临床结局的影响:一项基于人群的多队列研究
JHEP Rep. 2025 Mar 7;7(6):101388. doi: 10.1016/j.jhepr.2025.101388. eCollection 2025 Jun.
8
The Hepatoprotective Properties of Gentiopicroside, Sweroside, and Swertiamarin Against Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).龙胆苦苷、獐牙菜苷和獐牙菜苦苷对代谢功能障碍相关脂肪性肝病(MASLD)的肝脏保护特性。
Biomolecules. 2025 May 16;15(5):726. doi: 10.3390/biom15050726.
9
Clinical characteristics of lean and non-lean non-alcoholic fatty liver disease: a cross-sectional study.瘦型和非瘦型非酒精性脂肪性肝病的临床特征:一项横断面研究。
Nutr Metab (Lond). 2025 May 12;22(1):40. doi: 10.1186/s12986-025-00927-y.
10
Precision Imaging of Biothiols in Live Cells and Treatment Evaluation during the Development of Liver Injury via a Near-Infrared Fluorescent Probe.通过近红外荧光探针实现活细胞中生物硫醇的精准成像及肝损伤发展过程中的治疗评估
Chem Biomed Imaging. 2024 Aug 28;3(3):169-179. doi: 10.1021/cbmi.4c00048. eCollection 2025 Mar 24.